All told, 2013 was a good year for this blog. The blog averaged 83 hits per day, and our direct traffic was up over 21% to over 30,000 hits for the year. […]
Trade Secret Updates
From the Linkedin Chinese European Intellectual Property Group, CNet, the Taipei Times and other sources: six HTC employees have been indicted on the charge that they stole company secrets. The employees, including […]
End of Year Tid Bits
儿童强不睡,相守夜欢哗 – “Children try not to sleep, We noisily enjoy guarding the night.” Song dynasty poet, Su Shi. 守岁 – On the New Year There is China IP news even to […]
Student Externships at USPTO
The US Patent and Trademark Office has posted an announcement seeking applications for Externships. The Externships also include the USPTO Office of Policy and International Affairs, which includes the China team. Information is available at: […]
Who Went Where in 2013?
Many people in the China IP community changed jobs in 2014 – from seasoned experts to novices. The biggest changes were in the government, although other areas were not excluded. Amongst the […]
Positive Developments on IP in JCCT Outcomes
The 24th bilateral Joint Commission on Commerce and Trade concluded on December 20, 2013 at Diaoyutai State Guest House. The US “Fact Sheet” on this year’s JCCT is attached here. The JCCT […]
InterDigital – Safety of Executives Now at Issue in Ongoing China AML/IP Matter
The Internet and wire services are abuzz on December 16 with the latest update on the InterDigital saga. InterDigital’s executives will reportedly not travel to China to meet with the National Development […]
First Guiding Case on Intellectual Property
Stanford’s Mei Gechik reports through Don Clarke’s Chinalaw listserve that Stanford’s Guiding Case project has just made available an English translation of the first guiding case on intellectual property: Shenzhen Siruiman Fine Chemicals Co., Ltd. v. Shenzhen Kengzi […]
A Nail in the Coffin of Patent Linkage – New CFDA Rules
Today, December 13 is the last day for comments on proposed revisions to the China Food and Drug Administration’s proposed amendments to the Drug Registration Rules. Normally, one wouldn’t look to CFDA […]
Forecasting the Impact of the Third Plenum on IP Adjudication
What are the impacts of the resolution and spirits of the recent Third Plenum of the 18th Communist Party on rule of law in China, particularly commercial rule of law and IP? […]
